{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:01:01Z","timestamp":1791234061086,"version":"4.1.0"},"reference-count":5,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&T"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5582\/ddt.2015.01019","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T22:02:14Z","timestamp":1431986534000},"page":"142-143","source":"Crossref","is-referenced-by-count":15,"title":["Crizotinib-associated erythema multiforme in a lung cancer patient"],"prefix":"10.5582","volume":"9","author":[{"given":"Soichiro","family":"Sawamura","sequence":"first","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikko","family":"Kajihara","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Ichihara","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Jinnin","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Kohrogi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448:561-566.","DOI":"10.1038\/nature05945"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Camidge DR, Bang YJ, Kwak EL, et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase I study. Lancet Oncol. 2012; 13:1011-1019.","DOI":"10.1016\/S1470-2045(12)70344-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013; 368:2385-2394.","DOI":"10.1056\/NEJMoa1214886"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tamiya A, Okamoto I, Miyazaki M, Shimizu S, Kitaichi M, Nakagawa K. Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer. J Clin Oncol. 2013; 31:e15-17.","DOI":"10.1200\/JCO.2012.43.3730"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Park J1, Yoshida K, Kondo C, Shimizu J, Horio Y, Hijioka S, Hida T. Crizotinib-induced esophageal ulceration: a novel adverse event of crizotinib. Lung Cancer. 2013; 81:495-496.","DOI":"10.1016\/j.lungcan.2013.06.017"}],"container-title":["Drug Discoveries & Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T11:52:22Z","timestamp":1498218742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/9\/2\/9_2015.01019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2015.01019","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}